Diltiazem: Difference between revisions
Elcatracho (talk | contribs) |
|||
Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: [[Calcium channel blocker]] | *Type: [[Calcium channel blocker]] | ||
*Dosage Forms: | *Dosage Forms | ||
**IV: 25 mg/5 mL and 50 mg/10 mL bottles | |||
**Oral: 30 mg, 60 mg, 90 mg | |||
*Routes of Administration: IV, PO | *Routes of Administration: IV, PO | ||
*Common Trade Names: Cardizem | *Common Trade Names: Cardizem | ||
==Indications== | ==Indications== |
Revision as of 15:02, 30 April 2022
Administration
- Type: Calcium channel blocker
- Dosage Forms
- IV: 25 mg/5 mL and 50 mg/10 mL bottles
- Oral: 30 mg, 60 mg, 90 mg
- Routes of Administration: IV, PO
- Common Trade Names: Cardizem
Indications
Adult Dosing
- Loading dose = 0.25mg/kg (max=20mg) IV bolus over 2min
- If ineffective after 15min: 0.35mg/kg (max=25mg) over 2min
- If effective: Start infusion at 5-15mg/hr
Pediatric Dosing
- Contraindicated in pediatric patients <1yo
- See critical care quick reference for drug doses by weight
Special Populations
- Pregnancy Rating: C
- Lactation:
- Renal Dosing: Not studied, use caution
- Hepatic Dosing: Not studied, use caution
Contraindications
- Allergy to drug/class
- Infants <1yo
- Wide-complex tachycardia due to bypass tract (e.g. WPW)
- Symptomatic severe hypotension
- Sick sinus syndrome/2nd or 3rd degree heart block if no pacemaker
- PO: acute MI and pulmonary congestion
- Ventricular tachycardia
- Caution if:
- Hypertrophic cardiomyopathy
- LV dysfunction
- Concomitant beta-blockade
- Hepatic/renal impairment
- Heart failure
Adverse Reactions
Serious
Common
- Peripheral edema
- Elevated LFTs
- Headache
- Dizziness
- Nausea/vomiting, diarrhea, contipation
- Flushing, vasodilation
- Gingival hyperplagia
- Myalgia
- Bronchitis, sinus congestion, dypsnea
- Hemolytic anemia, thrombocytopenia
- Extrapyramidal symptoms
Pharmacology
- Onset of action = 2-3min (IV)
- Duration of action = 1-3hr (IV)
- Half life: 3-5h
- Metabolism: Hepatic
- Excretion: Urine/feces
Mechanism of Action
- Class IV - Inhibits Ca influx
- Slows AV nodal conduction